If you have been diagnosed with prostate cancer, we can help

We can help you To learn more about prostate cancer through guest speakers, books, DVDs and newsletters;
To make better decisions about what treatment to have (you can talk to men who have had the different treatments that you may be considering);
To meet others who are going through the same thing as you (avoid feeling isolated and alone)

We are a peer support group ( a group of men and women who have been affected by prostate cancer) who provide information, education and support. We are affiliated with the Prostate Cancer Foundation of Australia.

Evidence shows that:
Peer support can reduce the psychological stress associated with prostate cancer diagnosis; and
Support groups can improve the quality of life and well being of people with prostate cancer and their carers.

If you need help before our next meeting, please phone one of the people listed on the Contact Page.

April meeting, (in-person at the Uniting Church, Seddon St Ivanhoe and on Zoom): Tuesday April 18, guest speaker Dr Michael Wheatcroft, Chief Scientist, Telix Pharma.

The next meeting will be in-person and on Zoom.  It will be held on Tuesday April 18, 2023, starting at 10am.   The Zoom URL will be circulated via email. 

The guest speaker will be Dr Michael Wheatcroft, BSc (Hons) PhD (Cantab), Chief Scientist at Telix Pharma, which is developing precise ways to both locate prostate cancers and to deliver radio-pharmceuticals which treat them.

Dr Wheatcroft is Director of R&D at Telix. After completing a PhD in the Department of Biochemistry, Cambridge University, Mike worked at Cambridge Antibody Technology (now Medimmune,UK), a technology leader in the area of antibody engineering and protein sciences. After moving to Melbourne in 2010 he oversaw the preclinical development of several engineered antibody drug conjugates and clinical translation of novel antibody fragment in prostate and ovarian cancer, including radioimmunoconjugates. Since then Mike has worked in senior development roles at Medicines Development Limited (MDL), Hatchtech P/L and Starpharma Limited where he performed in a variety of managerial roles related to GMP production, clinical study support and nonclinical studies for a range of pharmaceutical and medical device products.